These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 19097668

  • 1. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 2. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 3. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Oct; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 4. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 5. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H, Bauduceau B, Ducorps M, Belmejdoub G, Poirier JM.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [Abstract] [Full Text] [Related]

  • 6. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 7. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.
    Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838
    [Abstract] [Full Text] [Related]

  • 8. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T, Khanna A, Kimball K, Wesson DE.
    Am J Kidney Dis; 2003 Jan 09; 41(1):13-21. PubMed ID: 12500217
    [Abstract] [Full Text] [Related]

  • 9. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 10. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G, Paczek L, Kropiewnicka E, Bartłomiejczyk I.
    Pol Merkur Lekarski; 2002 Nov 20; 13 Suppl 1():28-32. PubMed ID: 12621778
    [Abstract] [Full Text] [Related]

  • 11. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
    Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K, Kołodziejczyk Z.
    Scand J Urol Nephrol; 2011 Feb 20; 45(1):52-9. PubMed ID: 21034351
    [Abstract] [Full Text] [Related]

  • 12. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec 20; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 13. [Role of nocturnal blood pressure in the onset of diabetic nephropathy].
    Garcia C, Mayaudon H, Bordier L, Le Berre JP, Dupuy O, Bauduceau B.
    Arch Mal Coeur Vaiss; 2007 Aug 20; 100(8):668-72. PubMed ID: 17928773
    [Abstract] [Full Text] [Related]

  • 14. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun 20; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 15. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 16. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].
    Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, Peng LF, Xiong SL, Tang HH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May 21; 31(5):878-81. PubMed ID: 21602148
    [Abstract] [Full Text] [Related]

  • 17. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun 21; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct 21; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 19. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Oct 21; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH.
    Diabet Med; 2005 Jan 21; 22(1):14-20. PubMed ID: 15606685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.